Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD issues advice on cascade use of antibiotics
antibiotics
VMD has released a position statement in response to concerns over antibiotic use on the cascade.
Vets report conflict between responsible use and legal requirements

The Veterinary Medicines Directorate (VMD) is calling for professional bodies, veterinary schools and research institutes to work together to help vets make a more informed choice when prescribing antibiotics on the cascade.

Veterinary surgeons have raised concerns with the VMD about the difficulty of balancing the responsible use of antibiotics with legal requirements to prescribe UK authorised medicines before applying the cascade.

According to the VMD, vets are reporting an increasingly common challenge - where there is an authorised medicine that is a critically important antibiotic (CIA) and/or is not narrow spectrum. Under legislative requirements, this should be used as a first line treatment, rather than an unauthorised, non-CIA drug.

However, in some cases, other products authorised for use in other EU member states may be more appropriate in terms of the responsible use of antibiotics.

In response to these concerns, the VMD has issued its position statement on prescribing antibiotics under the cascade.

On a case-by-case basis, the directorate says it is "justified" to to prescribe an antibiotic on the cascade to reduce the development of resistance.

Vets must demonstrate that they have considered the most appropriate active substance(s), formulation, posology, current patterns of resistance in their locality, awareness of how to reduce selection pressure and other factors, such as good biosecurity, husbandry, hygiene and avoidance of surgical sepsis.

VMD is calling for the industry to collaborate on compiling up-to-date evidence and guidance to help vets make an informed choice based on scientific evidence and peer reviewed data.

Vets are also advised to keep up-to-date with the latest guidance provided by organisations including the BVA, BSAVA, BEVA, Pig Veterinary Society and Responsible Use of Medicines in Agriculture.

For the full position statement, see the VMD website: http://www.vmd.defra.gov.uk/pdf/cascade.pdf

Become a member or log in to add this story to your CPD history

Cold-water dip to raise funds for Vetlife

News Story 1
 The veterinary mental health charity Vetlife is inviting the veterinary community to join it for a sponsored cold-water dip.

The event will take place at Walpole Bay, Margate, on 17 May during Mental Health Awareness Week. Participants of all abilities can join in the challenge and are advised to bring a towel, a hot drink, a snack, and warm clothes to get changed into afterwards.

Those taking part are being asked to try to raise 100 each to support the work of the charity.

Details about how to take part can be found here

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.